The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 30, 2021
Filed:
Nov. 03, 2016
Applicants:
Genentech, Inc., South San Francisco, CA (US);
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Mark Merchant, South San Francisco, CA (US);
Deepak Sampath, South San Francisco, CA (US);
Marina Konopleva, Houston, TX (US);
Lina Han, Houston, TX (US);
Assignee:
Genentech, Inc., North San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5365 (2006.01); A61K 31/497 (2006.01); A61K 31/4523 (2006.01); A61K 45/06 (2006.01); A61K 31/496 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4523 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01); A61P 35/02 (2018.01); A61K 2300/00 (2013.01);
Abstract
The present invention is directed to a combination therapy involving a selective Bcl-2 inhibitor and a MEK inhibitor for the treatment of a patient in need of such a therapy. The patient in need of the combination therapy is suffering from cancer, such as acute myeloid leukemia.